| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.04 |